Suppr超能文献

非典型和传统抗精神病药物对精神分裂症患者加工速度降低和精神运动迟缓的影响:一项横断面探索性研究。

The effects of atypical and conventional antipsychotics on reduced processing speed and psychomotor slowing in schizophrenia: a cross-sectional exploratory study.

作者信息

Morrens Manuel, Hulstijn Wouter, Sabbe Bernard

机构信息

Collaborative Antwerp Psychiatric Research Institute, Antwerp, Belgium.

出版信息

Clin Ther. 2008 Apr;30(4):684-92. doi: 10.1016/j.clinthera.2008.04.012.

Abstract

BACKGROUND

Psychomotor slowing is an intrinsic feature of schizophrenia, but little is known about its nature or to what extent it is influenced by antipsychotics. The Symbol-Digit Substitution Test (SDST) is an appropriate tool for assessing reduced processing speed, whereas performance on copying tasks may be more useful in evaluating psychomotor slowing.

OBJECTIVE

The primary aim of this study was to investigate the effects of different antipsychotic agents on psychomotor slowing in patients with schizophrenia.

METHODS

This cross-sectional study compared performance on line- and figure-copying tasks in schizophrenic inpatients (matched for symptomatology, demographic variables, and duration of illness) treated with risperidone, olanzapine, other atypical antipsychotics (amisulpride, aripiprazole, clozapine, or quetiapine), or conventional antipsychotics (bromperidol, flupentixol, haloperidol, pimozide, or zuclopenthixol) and in healthy controls. Other tests administered included the SDST to assess processing speed, the California Verbal Learning Test to gauge verbal memory, the Letter-Number Sequencing task to assess working memory, and the Wisconsin Card Sorting Test to measure executive function. Comparisons were made between each patient group and healthy controls; between patient groups; and, post hoc, between atypical and conventional antipsychotics.

RESULTS

The study included 26 patients treated with risperidone, 24 treated with olanzapine, 25 treated with other atypical antipsychotics, 21 treated with conventional antipsychotics, and 25 healthy controls. The groups were well matched in terms of sex, educational level, mean doses, and duration of illness. The conventional-antipsychotic group was significantly older (P=0.026) and had significantly higher positive symptoms scores (P=0.031) on the Positive and Negative Syndrome Scale compared with the risperidone group. Patients treated with conventional antipsychotics had significantly greater slowing on the copying tasks compared with patients treated with atypical antipsychotics (P <or= 0.050 for 3 of 4 measures generated by the copying tasks). No significant differences were found on the classic neuropsychological tasks. All patient groups had poorer performance on the psychomotor measures compared with controls. No significant differences were found between the groups receiving atypical antipsychotics.

CONCLUSION

Based on performance on the line- and figure-copying tasks, atypical and conventional antipsychotics appeared to have differential effects on psychomotor slowing in these schizophrenic inpatients.

摘要

背景

精神运动迟缓是精神分裂症的一个内在特征,但对其本质或受抗精神病药物影响的程度知之甚少。符号数字替换测验(SDST)是评估处理速度降低的合适工具,而抄写任务的表现可能在评估精神运动迟缓方面更有用。

目的

本研究的主要目的是调查不同抗精神病药物对精神分裂症患者精神运动迟缓的影响。

方法

这项横断面研究比较了接受利培酮、奥氮平、其他非典型抗精神病药物(氨磺必利、阿立哌唑、氯氮平或喹硫平)或传统抗精神病药物(溴哌利多、氟哌噻吨、氟哌啶醇、匹莫齐特或珠氯噻醇)治疗的精神分裂症住院患者(在症状学、人口统计学变量和病程方面匹配)以及健康对照者在直线和图形抄写任务中的表现。实施的其他测试包括用于评估处理速度的SDST、用于测量言语记忆的加利福尼亚言语学习测验、用于评估工作记忆的字母数字排序任务以及用于测量执行功能的威斯康星卡片分类测验。对每个患者组与健康对照者之间、患者组之间以及事后非典型与传统抗精神病药物之间进行了比较。

结果

该研究纳入了26例接受利培酮治疗的患者、24例接受奥氮平治疗的患者、25例接受其他非典型抗精神病药物治疗的患者、21例接受传统抗精神病药物治疗的患者以及25名健康对照者。这些组在性别、教育水平、平均剂量和病程方面匹配良好。与利培酮组相比,传统抗精神病药物组年龄显著更大(P = 0.026),且在阳性和阴性症状量表上的阳性症状得分显著更高(P = 0.031)。与接受非典型抗精神病药物治疗的患者相比,接受传统抗精神病药物治疗的患者在抄写任务中的迟缓显著更明显(抄写任务产生的4项测量中有3项P≤0.050)。在经典神经心理学任务上未发现显著差异。与对照组相比,所有患者组在精神运动测量方面的表现均较差。接受非典型抗精神病药物治疗的组之间未发现显著差异。

结论

基于直线和图形抄写任务的表现,非典型和传统抗精神病药物对这些精神分裂症住院患者的精神运动迟缓似乎有不同影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验